Holen Sie sich die Stockscreener-App
336.79
0.09%
0.31
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$336.48
Offen:
$336.22
24-Stunden-Volumen:
2.95M
Relative Volume:
1.14
Marktkapitalisierung:
$181.77B
Einnahmen:
$37.30B
Nettoeinkommen (Verlust:
$7.80B
KGV:
23.42
EPS:
14.3793
Netto-Cashflow:
$8.60B
1W Leistung:
-0.74%
1M Leistung:
-0.36%
6M Leistung:
-2.51%
1J Leistung:
+18.78%
1-Tages-Spanne:
$333.06
$337.51
1-Wochen-Bereich:
$333.06
$342.49
52-Wochen-Spanne:
$267.83
$391.29
Amgen Inc Stock (AMGN) Company Profile
Firmenname
Amgen Inc
Sektor
Telefon
(805)447-1000
Adresse
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Compare AMGN vs LLY, JNJ, ABBV, MRK, AZN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AMGN
Amgen Inc
|
336.79 | 181.60B | 37.30B | 7.80B | 8.60B | 14.38 |
LLY
Lilly Eli Co
|
1,105.00 | 1.00T | 72.25B | 25.28B | 10.37B | 27.78 |
JNJ
Johnson Johnson
|
225.33 | 555.59B | 96.36B | 21.04B | 17.80B | 8.6488 |
ABBV
Abbvie Inc
|
217.72 | 386.27B | 62.82B | 3.60B | 19.98B | 2.0274 |
MRK
Merck Co Inc
|
118.72 | 296.11B | 65.51B | 8.93B | 14.12B | 3.5532 |
AZN
Astrazeneca Plc
|
185.67 | 287.42B | 60.48B | 10.40B | 8.05B | 3.3297 |
Amgen Inc Stock (AMGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-21 | Eingeleitet | Canaccord Genuity | Hold |
| 2026-03-10 | Eingeleitet | Jefferies | Hold |
| 2026-02-20 | Eingeleitet | Barclays | Equal Weight |
| 2026-01-20 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2026-01-07 | Fortgesetzt | UBS | Buy |
| 2025-12-05 | Hochstufung | Erste Group | Hold → Buy |
| 2025-11-24 | Fortgesetzt | Truist | Hold |
| 2025-11-13 | Eingeleitet | Scotiabank | Sector Outperform |
| 2025-09-03 | Fortgesetzt | Raymond James | Mkt Perform |
| 2025-05-20 | Fortgesetzt | Guggenheim | Neutral |
| 2025-04-22 | Fortgesetzt | Cantor Fitzgerald | Neutral |
| 2024-12-10 | Fortgesetzt | BofA Securities | Underperform |
| 2024-11-15 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-11-14 | Eingeleitet | Citigroup | Neutral |
| 2024-10-17 | Eingeleitet | Bernstein | Outperform |
| 2024-10-14 | Herabstufung | Truist | Buy → Hold |
| 2024-09-27 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-08-07 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-05-03 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2024-05-03 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2024-03-28 | Fortgesetzt | Raymond James | Mkt Perform |
| 2024-02-07 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2023-12-21 | Hochstufung | Daiwa Securities | Neutral → Buy |
| 2023-12-19 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2023-12-12 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-11-09 | Eingeleitet | Deutsche Bank | Hold |
| 2023-11-02 | Hochstufung | Truist | Hold → Buy |
| 2023-10-20 | Fortgesetzt | JP Morgan | Neutral |
| 2023-10-17 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2023-10-11 | Fortgesetzt | BofA Securities | Neutral |
| 2023-09-06 | Eingeleitet | HSBC Securities | Buy |
| 2023-04-24 | Bestätigt | Oppenheimer | Outperform |
| 2023-03-13 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-02-13 | Bestätigt | Truist | Buy |
| 2022-11-18 | Eingeleitet | Credit Suisse | Underperform |
| 2022-10-31 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2022-10-11 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-05-23 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2022-02-09 | Bestätigt | Barclays | Equal Weight |
| 2022-02-09 | Bestätigt | Jefferies | Buy |
| 2022-02-09 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2022-02-09 | Bestätigt | Oppenheimer | Outperform |
| 2022-02-09 | Bestätigt | Wells Fargo | Equal Weight |
| 2022-01-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-12-09 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2021-12-06 | Eingeleitet | Goldman | Buy |
| 2021-11-19 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2021-09-23 | Herabstufung | Daiwa Securities | Outperform → Neutral |
| 2021-09-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-29 | Eingeleitet | Daiwa Securities | Buy |
| 2020-10-28 | Eingeleitet | UBS | Neutral |
| 2020-10-26 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-10-12 | Hochstufung | Truist | Hold → Buy |
| 2020-10-09 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2020-10-09 | Herabstufung | Truist | Buy → Hold |
| 2020-10-08 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2020-04-15 | Fortgesetzt | Guggenheim | Neutral |
| 2020-03-31 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-03-30 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-03-05 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2020-02-27 | Eingeleitet | Barclays | Equal Weight |
| 2020-01-31 | Herabstufung | Robert W. Baird | Neutral → Underperform |
| 2020-01-21 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2019-12-24 | Eingeleitet | Raymond James | Mkt Perform |
| 2019-12-17 | Fortgesetzt | Morgan Stanley | Overweight |
| 2019-11-12 | Eingeleitet | SunTrust | Buy |
| 2019-11-05 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2019-10-17 | Fortgesetzt | BofA/Merrill | Neutral |
| 2019-08-19 | Herabstufung | Mizuho | Buy → Neutral |
| 2019-05-23 | Hochstufung | Citigroup | Neutral → Buy |
Alle ansehen
Amgen Inc Aktie (AMGN) Neueste Nachrichten
Nomura Asset Management Co. Ltd. Has $97.92 Million Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by Commonwealth of Pennsylvania Public School Empls Retrmt SYS - MarketBeat
Amgen Stock: Is AMGN Outperforming the Healthcare Sector? - Barchart.com
Amgen Inc. stock (US0311621009): shares little changed as investors digest recent earnings and drug - AD HOC NEWS
Norges Bank Buys New Position in Amgen Inc. $AMGN - MarketBeat
Savant Capital LLC Trims Stock Position in Amgen Inc. $AMGN - MarketBeat
Eurizon Capital SGR S.p.A. Invests $86.74 Million in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. stock (US0311621009): Upcoming Jefferies appearance keeps focus on US biotech heavyweight - AD HOC NEWS
Amgen's CFO and senior execs to speak at Jefferies healthcare event - Stock Titan
Amgen Inc. stock (US0311621009): shares steady as Nasdaq biotech name trades near recent range - AD HOC NEWS
Amgen Inc. $AMGN Shares Acquired by National Pension Service - MarketBeat
Ilmarinen Mutual Pension Insurance Co Has $28.54 Million Position in Amgen Inc. $AMGN - MarketBeat
Intech Investment Management LLC Grows Holdings in Amgen Inc. $AMGN - MarketBeat
17,124 Shares in Amgen Inc. $AMGN Acquired by Fideuram Asset Management Ireland dac - MarketBeat
RTX, Wells Fargo (WFC) And Amgen (AMGN) Face Mixed Outlooks As Analysts Weigh Growth Against Key Risks - foreignpolicyjournal.com
Amgen Inc. stock (US0311621009): Shares steadier as S&P 500 biotech name trades around recent range - AD HOC NEWS
Has Amgen Stock Quietly Become a Value Opportunity? - Trefis
Amgen Inc. stock (US0311621009): Venture arm backs cold-chain specialist Ember LifeSciences - AD HOC NEWS
Amgen Inc. $AMGN Shares Purchased by Smith Chas P & Associates PA Cpas - MarketBeat
Amgen Inc. $AMGN Stake Boosted by Integrity Alliance LLC. - MarketBeat
Foundations Investment Advisors LLC Buys 3,292 Shares of Amgen Inc. $AMGN - MarketBeat
Geode Capital Management LLC Has $4.67 Billion Stock Position in Amgen Inc. $AMGN - MarketBeat
AMGN Technical Analysis | Trend, Signals & Chart Patterns | AMGEN INC (NASDAQ:AMGN) - ChartMill
Amgen stock (US0311621009): Focus on earnings, pipeline, and US market exposure - AD HOC NEWS
Amgen Inc. stock (US0311621009): Weight-loss trial update keeps biotech giant in focus - AD HOC NEWS
Amgen Inc. stock (US0311621009): Investors weigh steady Q1 growth, Horizon deal integration and pipe - AD HOC NEWS
Amgen Presents 2nd Community Day as L.A. Builds Momentum for Kick Off of FIFA World Cup 2026 - Amgen
President Trump Loaded Up on Eli Lilly in Q1. Should You Buy the Obesity Drug Stock Too? - The Motley Fool
Amgen stock (US0311621009): Shares edge up after latest trading update - AD HOC NEWS
Novo Nordisk vs. Amgen: Which Pharma Stock Is the Better Buy? - Yahoo Finance
Is It Too Late To Consider Amgen (AMGN) After Its Strong Multi Year Share Price Run? - simplywall.st
Is Trending Stock Amgen Inc. (AMGN) a Buy Now? - MSN
King Luther Capital Management Corp Increases Position in Amgen Inc. $AMGN - MarketBeat
Amgen Drug Gets New Warnings in Japan After Patient Deaths - WSJ
The Zacks Analyst Blog Highlights RTX, Wells Fargo, Amgen, Daily Journal and Tandy Leather - Zacks Investment Research
Amgen Named One of Newsweek’s Most Trustworthy Companies in America 2026 - Amgen
Top Stock Reports for RTX, Wells Fargo & Amgen - Yahoo Finance
Amgen Inc. (AMGN) is attracting investor attention: Here is what you should know - MSN
Amgen's Growth Engine Is Just Getting Started (NASDAQ:AMGN) - Seeking Alpha
AMGN Stock Down 13% in 3 Months: Buy the Dip or Book Profits? - TradingView
Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
AMGN Fairly Valued by DCF at $292 - GuruFocus
Assessing Amgen (AMGN) Valuation After Japan Safety Concerns Over Rare Disease Drug - simplywall.st
Fisher Asset Management LLC Purchases 118,273 Shares of Amgen Inc. $AMGN - MarketBeat
Allstate Corp Has $13.13 Million Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen stock (US0311621009): CFO retirement and earnings strength keep focus on guidance - AD HOC NEWS
Amgen Drug Reviewed Amid Deaths - Los Angeles Business Journal
Mita Ganatra Joins Amgen India as Executive Director, Finance - hrtoday.in
Amgen (AMGN) Announces Retirement of CFO Peter Griffith - Insider Monkey
Standing Bone Strong: Introducing a New Awareness Symbol for Osteoporosis - Amgen
Wealthquest Corp Acquires Shares of 3,374 Amgen Inc. $AMGN - MarketBeat
Finanzdaten der Amgen Inc-Aktie (AMGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.31%
0.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):